Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial results for the third quarter and first nine months of fiscal 2022 on Monday, February 28, 2022, after...
Prixa Bersama AdMedika (Prixa is with AdMedika) Strategic Collaboration Providing Access to the Digital Transformation of Healthcare in Indonesia
Prixa conducts strategic collaborations by providing cashless digital healthcare that includes teleconsultation and e-prescriptions to provide convenience to AdMedika users Increasing trend of digital consumers is carrying hope to the growth of revenue in digital health industry Strategic collaboration with AdMedika is a way to provide the best health services for the community & digital transformation....
Dr. Somporn Kumphong is named Executive Director of Global Healthcare Accreditation for the Asia Pacific region.
WEST PALM BEACH, Fla., Feb. 23, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) is pleased to announce that Dr. Somporn Kumphong has been named Executive Director of Global Healthcare Accreditation (GHA) for the Asia Pacific region. Based in Bangkok, Thailand, Dr. Somporn Kumphong has over 25 years of experience in health care, with...
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced interim data from a Phase II clinical trial of STP705, a siRNA (small interfering RNA) therapeutic, for the treatment of cutaneous basal cell carcinoma (BCC). The interim data, which examines results from...
Simcere Pharma (2096.HK) Announces a Positive Profit Alert
HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (the "Company", together with its subsidiaries, the "Group"; stock code: 2096.HK), announces a positive profit alert. Based on a preliminary assessment of the Group's unaudited consolidated management accounts for the year ended December 31, 2021, it is expected that the Group will record a profit attributable to...
Citadel Health: Pandemic highlights data revolution urgency
LONDON, Feb. 23, 2022 /PRNewswire/ -- David Wells, the biomedical scientist who spearheaded NHS England's COVID-19 testing response, says the pandemic's scale and impact highlights the urgent need to reshape diagnostics worldwide. Mr Wells led the NHS drive to build a nationwide testing service from scratch as the pandemic took hold. The respected industry leader, who recently joined the...
BIORCHESTRA Announces 45 Million USD Series C Fundraising
SEOUL, South Korea, Feb. 23, 2022 /PRNewswire/ -- BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using its proprietary RNA-based drug and drug delivery platforms. Today, BIORCHESTRA announced the completion of its 45 million USD (54 billion KRW) Series C Fundraising as of 22nd February...
Radiaction Opens First EU Radiation Protection Center of Excellence in Collaboration with Mazowiecki Hospital in Ostrołęka, Poland
TEL AVIV, Israel, Feb. 22, 2022 /PRNewswire/ -- Radiaction Medical Ltd. ("Radiaction"), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, has entered into a new collaboration with the Interventional Cardiology unit of Mazowiecki Hospital in Ostroleka, Poland. The hospital has received the first installed system in the EU to protect...
Havas Health & You Announces Expansion Across APAC, Including Southeast Asia (SEA) Village
SINGAPORE, Feb. 23, 2022 /PRNewswire/ -- In the next decade, APAC will represent 40% of total growth in global health spending, expanding at a rate almost double that of the rest of the world – making both presence and investment in APAC more critical than ever. To help Havas Health & You (HH&Y)...
XACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic System
The XACT ACE® Robotic System addresses the limitations of traditional manual methods and other image-guided percutaneous intervention systems. SAN ANTONIO, Feb. 22, 2022 /PRNewswire/ -- Frost & Sullivan recently evaluated the North American percutaneous procedure system industry and, based on its findings, recognizes XACT Robotics with the 2021 North American Percutaneous Procedure System Technology Innovation Leadership Award. The company's...
